Additionally, Todd et al. investigated the immunoregulatory effects of IL-2 in autoimmune diseases, reporting improved serologic markers and organ-specific symptoms in SLE patients after repeated Ld-IL-2 cycles [16]. This evidence concerns the gene IL2 and autoimmune disease.